vs
太平洋生物科学（ASMB）与Velo3D, Inc.（VELO）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是Velo3D, Inc.的1.1倍（$10.8M vs $9.4M），太平洋生物科学净利率更高（-85.2% vs -231.9%，领先146.7%），太平洋生物科学同比增速更快（57.6% vs -25.2%），Velo3D, Inc.自由现金流更多（$-8.3M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Velo3D是全球领先的金属3D打印解决方案提供商，主营工业级金属3D打印机、配套专用加工软件及高性能金属材料，主要服务航空航天、国防、能源、半导体等高端制造领域，可生产传统工艺难以实现的复杂高精度金属零部件。
ASMB vs VELO — 直观对比
营收规模更大
ASMB
是对方的1.1倍
$9.4M
营收增速更快
ASMB
高出82.8%
-25.2%
净利率更高
ASMB
高出146.7%
-231.9%
自由现金流更多
VELO
多$6.8M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $9.4M |
| 净利润 | $-9.2M | $-21.9M |
| 毛利率 | — | -73.6% |
| 营业利润率 | -100.9% | -231.0% |
| 净利率 | -85.2% | -231.9% |
| 营收同比 | 57.6% | -25.2% |
| 净利润同比 | 4.3% | -2.9% |
| 每股收益（稀释后） | $-0.72 | $-0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBVELO
| Q4 25 | — | $9.4M | ||
| Q3 25 | $10.8M | $13.6M | ||
| Q2 25 | $9.6M | $13.6M | ||
| Q1 25 | $9.4M | $9.3M | ||
| Q4 24 | $7.4M | $12.6M | ||
| Q3 24 | $6.8M | $8.2M | ||
| Q2 24 | $8.5M | $10.3M | ||
| Q1 24 | $5.8M | $9.8M |
净利润ASMBVELO
| Q4 25 | — | $-21.9M | ||
| Q3 25 | $-9.2M | $-11.2M | ||
| Q2 25 | $-10.2M | $-13.3M | ||
| Q1 25 | $-8.8M | $-25.0M | ||
| Q4 24 | — | $-21.3M | ||
| Q3 24 | $-9.6M | $-21.9M | ||
| Q2 24 | $-11.2M | $935.0K | ||
| Q1 24 | $-9.1M | $-27.5M |
毛利率ASMBVELO
| Q4 25 | — | -73.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | -11.7% | ||
| Q1 25 | — | 7.5% | ||
| Q4 24 | — | -3.5% | ||
| Q3 24 | — | 49.4% | ||
| Q2 24 | — | -28.0% | ||
| Q1 24 | — | -28.8% |
营业利润率ASMBVELO
| Q4 25 | — | -231.0% | ||
| Q3 25 | -100.9% | -73.3% | ||
| Q2 25 | -115.2% | -85.4% | ||
| Q1 25 | -105.5% | -123.6% | ||
| Q4 24 | — | -167.0% | ||
| Q3 24 | -160.1% | -213.8% | ||
| Q2 24 | -143.0% | -187.7% | ||
| Q1 24 | -185.5% | -211.1% |
净利率ASMBVELO
| Q4 25 | — | -231.9% | ||
| Q3 25 | -85.2% | -82.0% | ||
| Q2 25 | -105.9% | -97.7% | ||
| Q1 25 | -93.6% | -268.4% | ||
| Q4 24 | — | -168.5% | ||
| Q3 24 | -140.4% | -265.3% | ||
| Q2 24 | -130.7% | 9.0% | ||
| Q1 24 | -156.9% | -281.2% |
每股收益（稀释后）ASMBVELO
| Q4 25 | — | $-0.87 | ||
| Q3 25 | $-0.72 | $-0.65 | ||
| Q2 25 | $-1.33 | $-0.94 | ||
| Q1 25 | $-1.17 | $-1.87 | ||
| Q4 24 | — | $7.06 | ||
| Q3 24 | $-1.51 | $-35.52 | ||
| Q2 24 | $-1.98 | $1.65 | ||
| Q1 24 | $-1.66 | $-55.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $39.0M |
| 总债务越低越好 | — | $31.0M |
| 股东权益账面价值 | $182.7M | $38.2M |
| 总资产 | $240.0M | $105.3M |
| 负债/权益比越低杠杆越低 | — | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资ASMBVELO
| Q4 25 | — | $39.0M | ||
| Q3 25 | $22.5M | $11.8M | ||
| Q2 25 | $24.0M | $854.0K | ||
| Q1 25 | $23.4M | $3.9M | ||
| Q4 24 | $38.3M | $1.2M | ||
| Q3 24 | $28.5M | $1.6M | ||
| Q2 24 | $19.2M | $3.2M | ||
| Q1 24 | $18.7M | $10.9M |
总债务ASMBVELO
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $44.0M |
股东权益ASMBVELO
| Q4 25 | — | $38.2M | ||
| Q3 25 | $182.7M | $29.9M | ||
| Q2 25 | $18.1M | $21.4M | ||
| Q1 25 | $27.1M | $32.8M | ||
| Q4 24 | $33.4M | $39.7M | ||
| Q3 24 | $26.0M | $34.4M | ||
| Q2 24 | $34.7M | $52.1M | ||
| Q1 24 | $32.6M | $45.5M |
总资产ASMBVELO
| Q4 25 | — | $105.3M | ||
| Q3 25 | $240.0M | $93.7M | ||
| Q2 25 | $80.8M | $78.4M | ||
| Q1 25 | $99.0M | $91.3M | ||
| Q4 24 | $119.2M | $89.2M | ||
| Q3 24 | $100.3M | $110.8M | ||
| Q2 24 | $115.3M | $116.7M | ||
| Q1 24 | $119.9M | $136.1M |
负债/权益比ASMBVELO
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.97× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-7.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-8.3M |
| 自由现金流率自由现金流/营收 | -140.7% | -88.3% |
| 资本支出强度资本支出/营收 | 0.4% | 6.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBVELO
| Q4 25 | — | $-7.7M | ||
| Q3 25 | $-15.1M | $-6.0M | ||
| Q2 25 | $-16.8M | $-1.2M | ||
| Q1 25 | $-23.4M | $-12.3M | ||
| Q4 24 | $-51.1M | $-2.2M | ||
| Q3 24 | $-15.2M | $-2.0M | ||
| Q2 24 | $-17.1M | $-8.0M | ||
| Q1 24 | $-18.4M | $-20.5M |
自由现金流ASMBVELO
| Q4 25 | — | $-8.3M | ||
| Q3 25 | $-15.2M | $-6.3M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | $-2.2M | ||
| Q3 24 | — | $-2.0M | ||
| Q2 24 | $-17.1M | $-8.0M | ||
| Q1 24 | $-18.4M | $-20.5M |
自由现金流率ASMBVELO
| Q4 25 | — | -88.3% | ||
| Q3 25 | -140.7% | -46.5% | ||
| Q2 25 | — | -22.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | -17.7% | ||
| Q3 24 | — | -24.2% | ||
| Q2 24 | -200.6% | -77.1% | ||
| Q1 24 | -317.7% | -209.8% |
资本支出强度ASMBVELO
| Q4 25 | — | 6.4% | ||
| Q3 25 | 0.4% | 2.3% | ||
| Q2 25 | 0.0% | 13.3% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.2% | 0.0% | ||
| Q1 24 | 0.2% | 0.1% |
现金转化率ASMBVELO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -8.52× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
